Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isidro B Salusky

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Pediatric Nephrology (Berlin, Germany)|October 12, 2002
Cell biology of renal osteodystrophyBeatriz D Kuizon, Isidro B Salusky
Pediatric Nephrology (Berlin, Germany)|February 6, 2013
Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in childrenKatherine Wesseling-Perry, Isidro B Salusky
Seminars in Nephrology|March 8, 2013
Chronic kidney disease: mineral and bone disorder in childrenKatherine Wesseling-Perry, Isidro B Salusky
Current Osteoporosis Reports|April 30, 2017
Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone DisorderMark R Hanudel, Isidro B Salusky
Kidney International|May 1, 2010
Ironing out the phosphorus problemJoshua J Zaritsky, Isidro B Salusky
Journal of the American Society of Nephrology : JASN|August 24, 2001
Adynamic renal osteodystrophy: is there a problem?Isidro B Salusky, William G Goodman
Current Opinion in Nephrology and Hypertension|May 22, 2009
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?Katherine Wesseling-Perry, Isidro B Salusky
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 2, 2010
FGF-23: More than a regulator of renal phosphate handling?Harald Jüppner, Myles Wolf, Isidro B Salusky
Kidney International|October 16, 2016
Fibroblast growth factor 23: fueling the fireMark Hanudel, Harald Jüppner, Isidro B Salusky
Drugs|May 29, 2019
Mechanism of Action and Clinical Attributes of Auryxia<sup>®</sup> (Ferric Citrate)Tomas Ganz, Avi Bino, Isidro B Salusky
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Pediatric Nephrology (Berlin, Germany)|October 12, 2002
Cell biology of renal osteodystrophyBeatriz D Kuizon, Isidro B Salusky
Pediatric Nephrology (Berlin, Germany)|February 6, 2013
Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in childrenKatherine Wesseling-Perry, Isidro B Salusky
Seminars in Nephrology|March 8, 2013
Chronic kidney disease: mineral and bone disorder in childrenKatherine Wesseling-Perry, Isidro B Salusky
Current Osteoporosis Reports|April 30, 2017
Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone DisorderMark R Hanudel, Isidro B Salusky
Kidney International|May 1, 2010
Ironing out the phosphorus problemJoshua J Zaritsky, Isidro B Salusky
Journal of the American Society of Nephrology : JASN|August 24, 2001
Adynamic renal osteodystrophy: is there a problem?Isidro B Salusky, William G Goodman
Current Opinion in Nephrology and Hypertension|May 22, 2009
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?Katherine Wesseling-Perry, Isidro B Salusky
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 2, 2010
FGF-23: More than a regulator of renal phosphate handling?Harald Jüppner, Myles Wolf, Isidro B Salusky
Kidney International|October 16, 2016
Fibroblast growth factor 23: fueling the fireMark Hanudel, Harald Jüppner, Isidro B Salusky
Drugs|May 29, 2019
Mechanism of Action and Clinical Attributes of Auryxia<sup>®</sup> (Ferric Citrate)Tomas Ganz, Avi Bino, Isidro B Salusky
Pageof 16